Treatment of drug-eluting stent restenosis: A sandwich may not be the best combo
Guardado en:
Autor principal: | |
---|---|
Formato: | JOUR |
Materias: | |
Acceso en línea: | http://hdl.handle.net/20.500.12110/paper_15221946_v71_n5_p599_Belardi |
Aporte de: |
id |
todo:paper_15221946_v71_n5_p599_Belardi |
---|---|
record_format |
dspace |
spelling |
todo:paper_15221946_v71_n5_p599_Belardi2023-10-03T16:20:43Z Treatment of drug-eluting stent restenosis: A sandwich may not be the best combo Belardi, J. bare metal stent coronary stent drug eluting stent human in-stent restenosis note percutaneous coronary intervention percutaneous transluminal angioplasty prognosis treatment response Angioplasty, Transluminal, Percutaneous Coronary Cardiovascular Agents Cardiovascular Diseases Coronary Restenosis Drug-Eluting Stents Humans Metals Patient Selection Practice Guidelines as Topic Prosthesis Design Risk Assessment Sirolimus Stents Time Factors Treatment Outcome JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_15221946_v71_n5_p599_Belardi |
institution |
Universidad de Buenos Aires |
institution_str |
I-28 |
repository_str |
R-134 |
collection |
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) |
topic |
bare metal stent coronary stent drug eluting stent human in-stent restenosis note percutaneous coronary intervention percutaneous transluminal angioplasty prognosis treatment response Angioplasty, Transluminal, Percutaneous Coronary Cardiovascular Agents Cardiovascular Diseases Coronary Restenosis Drug-Eluting Stents Humans Metals Patient Selection Practice Guidelines as Topic Prosthesis Design Risk Assessment Sirolimus Stents Time Factors Treatment Outcome |
spellingShingle |
bare metal stent coronary stent drug eluting stent human in-stent restenosis note percutaneous coronary intervention percutaneous transluminal angioplasty prognosis treatment response Angioplasty, Transluminal, Percutaneous Coronary Cardiovascular Agents Cardiovascular Diseases Coronary Restenosis Drug-Eluting Stents Humans Metals Patient Selection Practice Guidelines as Topic Prosthesis Design Risk Assessment Sirolimus Stents Time Factors Treatment Outcome Belardi, J. Treatment of drug-eluting stent restenosis: A sandwich may not be the best combo |
topic_facet |
bare metal stent coronary stent drug eluting stent human in-stent restenosis note percutaneous coronary intervention percutaneous transluminal angioplasty prognosis treatment response Angioplasty, Transluminal, Percutaneous Coronary Cardiovascular Agents Cardiovascular Diseases Coronary Restenosis Drug-Eluting Stents Humans Metals Patient Selection Practice Guidelines as Topic Prosthesis Design Risk Assessment Sirolimus Stents Time Factors Treatment Outcome |
format |
JOUR |
author |
Belardi, J. |
author_facet |
Belardi, J. |
author_sort |
Belardi, J. |
title |
Treatment of drug-eluting stent restenosis: A sandwich may not be the best combo |
title_short |
Treatment of drug-eluting stent restenosis: A sandwich may not be the best combo |
title_full |
Treatment of drug-eluting stent restenosis: A sandwich may not be the best combo |
title_fullStr |
Treatment of drug-eluting stent restenosis: A sandwich may not be the best combo |
title_full_unstemmed |
Treatment of drug-eluting stent restenosis: A sandwich may not be the best combo |
title_sort |
treatment of drug-eluting stent restenosis: a sandwich may not be the best combo |
url |
http://hdl.handle.net/20.500.12110/paper_15221946_v71_n5_p599_Belardi |
work_keys_str_mv |
AT belardij treatmentofdrugelutingstentrestenosisasandwichmaynotbethebestcombo |
_version_ |
1782027197586866176 |